Category: Biotech

Unicycive Therapeutics, Inc., (Nasdaq: UNCY) has raised up to $130M to support its New Drug Application (NDA) submission with the FDA for approval and potential… [Read More]

Commercial-stage biopharmaceutical company, BridgeBio (Nasdaq: BBIO), has announced positive results from its PROPEL2 Phase 2 clinical trial demonstrating potential best-in-class efficacy and a clean safety… [Read More]

Lexaria Bioscience (NASDAQ: LEXX) shared the notable results of its recent diabetes animal model study, with positive outcomes including weight loss and improved triglyceride and… [Read More]

Incannex Healthcare Limited (Nasdaq: IXHL), a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic medicine therapies for unmet medical needs, has engaged a manufacturer… [Read More]

Authorities in Equatorial Guinea are working to contain an outbreak of Marburg virus that began in February 2023 and has resulted in 11 deaths and… [Read More]

Lipella Pharmaceuticals (Nasdaq: LIPO), has appointed a five-member Scientific Advisory Board in oral health to focus on the development of LP-310 for the treatment of… [Read More]

Global gene therapy company, Orchard Therapeutics (Nasdaq: ORTX) has reached an agreement that will allow reimbursed access to Libmeldy for eligible metachromatic leukodystrophy (MLD) patients… [Read More]

Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), an Australian pharmaceutical company, has commenced a Phase 2 clinical trial investigating IHL-675A as a treatment for rheumatoid… [Read More]

Biopharmaceutical company, Cingulate (Nasdaq: CING) has announced positive topline results in its fed/fast study of CTx-1301, demonstrating the drug can be taken with or without… [Read More]

Clinical-stage biotechnology company, Chemomab (Nasdaq: CMMB) has received clearance from the FDA for its Investigational New Drug (IND) Application to evaluate CM-101 in a Phase… [Read More]